Enfusion Inc ENFN shares are trading higher by 20% to $11.06 Monday afternoon following a report suggesting the company is attracting takeover interest.
What Else?
Enfusion is drawing takeover interest from private equity firms and strategic buyers, including Francisco Partners, Vista Equity Partners and Irenic Capital Management, according to anonymous sources cited by Reuters.
Enfusion has faced executive turnover, with its CEO and CFO resigning last year. Irenic Capital Management is in talks with Enfusion's new CEO about a potential transaction at a premium.
See Also: Goldman Sachs Drops Bullish Stance On Tesla Stock
Per Reuters, no comments were provided by Francisco Partners, Vista Equity Partners or Irenic. Additionally, there is no certainty regarding a deal. Irenic may collaborate with a software-focused private equity firm for the acquisition.
According to data from Benzinga Pro, ENFN has a 52-week high of $16.76 and a 52-week low of $7.37.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
